Globus Medical (GMED) Consolidated Net Income (2011 - 2026)
Globus Medical (GMED) posted Consolidated Net Income of $124.3 million for Q1 2026, down 11.59% on a QoQ basis from $140.6 million in Q4 2025, and up 64.72% year-over-year from $75.5 million in Q1 2025.
Globus Medical (GMED) Consolidated Net Income (2011 - 2026) Analysis & Trends
Globus Medical's Consolidated Net Income history runs 16 years deep, the most recent figure standing at $124.3 million for Q1 2026.
- Quarterly Consolidated Net Income rose 64.72% year-over-year to $124.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $586.7 million (up 216.18% YoY) and the FY2025 annual result came in at $537.9 million, up 422.28% from the prior year.
- Consolidated Net Income was $124.3 million for Q1 2026 at Globus Medical, down from $140.6 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $202.8 million in Q2 2025 and bottomed at -$7.2 million in Q1 2024.
- A 5-year average of $62.1 million and a median of $49.1 million in 2023 frame the typical range for Consolidated Net Income.
- Peak annual rise in Consolidated Net Income reached 5093.99% in 2024, while the deepest fall reached 114.57% in 2024.
- Globus Medical's Consolidated Net Income stood at $27.7 million in 2022, then plunged by 45.79% to $15.0 million in 2023, then surged by 76.3% to $26.5 million in 2024, then surged by 430.44% to $140.6 million in 2025, then declined by 11.59% to $124.3 million in 2026.
- Business Quant data shows GMED's Consolidated Net Income at $124.3 million in Q1 2026, $140.6 million in Q4 2025, and $119.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 273.95 Mn |
| 10 | Globus Medical | 10.59 Bn | 9.97 Bn | 525.79 Mn | 124.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 124.30 Mn |
| Dec 31, 2025 | 140.59 Mn |
| Sep 30, 2025 | 118.97 Mn |
| Jun 30, 2025 | 202.85 Mn |
| Mar 31, 2025 | 75.46 Mn |
| Dec 31, 2024 | 26.51 Mn |
| Sep 30, 2024 | 51.84 Mn |
| Jun 30, 2024 | 31.76 Mn |
| Mar 31, 2024 | -7.16 Mn |
| Dec 31, 2023 | 15.03 Mn |
| Sep 30, 2023 | 998,000.00 |
| Jun 30, 2023 | 57.71 Mn |
| Mar 31, 2023 | 49.13 Mn |
| Dec 31, 2022 | 27.74 Mn |
| Sep 30, 2022 | 47.43 Mn |
| Jun 30, 2022 | 54.59 Mn |
| Mar 31, 2022 | 38.08 Mn |
| Dec 31, 2021 | -169.71 Mn |
| Sep 30, 2021 | 47.21 Mn |
| Jun 30, 2021 | 41.55 Mn |